These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20404029)

  • 1. Induced pluripotent stem cells: what lies beyond the paradigm shift.
    Cox JL; Rizzino A
    Exp Biol Med (Maywood); 2010 Feb; 235(2):148-58. PubMed ID: 20404029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
    Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
    Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Oct4-GFP spermatogonial stem cell line and its application in the reprogramming studies.
    Youn H; Kim SH; Choi KA; Kim S
    J Cell Biochem; 2013 Apr; 114(4):920-8. PubMed ID: 23097321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular coupling of Tsix regulation and pluripotency.
    Navarro P; Oldfield A; Legoupi J; Festuccia N; Dubois A; Attia M; Schoorlemmer J; Rougeulle C; Chambers I; Avner P
    Nature; 2010 Nov; 468(7322):457-60. PubMed ID: 21085182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells.
    Fong YW; Inouye C; Yamaguchi T; Cattoglio C; Grubisic I; Tjian R
    Cell; 2011 Sep; 147(1):120-31. PubMed ID: 21962512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.
    Pereira CF; Terranova R; Ryan NK; Santos J; Morris KJ; Cui W; Merkenschlager M; Fisher AG
    PLoS Genet; 2008 Sep; 4(9):e1000170. PubMed ID: 18773085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.
    Mao J; Zhang Q; Ye X; Liu K; Liu L
    Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct reprogramming of human neural stem cells by OCT4.
    Kim JB; Greber B; Araúzo-Bravo MJ; Meyer J; Park KI; Zaehres H; Schöler HR
    Nature; 2009 Oct; 461(7264):649-3. PubMed ID: 19718018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin 6: a novel surface marker for characterizing mouse pluripotent stem cells.
    Wang L; Xue Y; Shen Y; Li W; Cheng Y; Yan X; Shi W; Wang J; Gong Z; Yang G; Guo C; Zhou Y; Wang X; Zhou Q; Zeng F
    Cell Res; 2012 Jun; 22(6):1082-5. PubMed ID: 22565286
    [No Abstract]   [Full Text] [Related]  

  • 12. Reprogramming of human somatic cells to pluripotency with defined factors.
    Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
    Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tbx3 improves the germ-line competency of induced pluripotent stem cells.
    Han J; Yuan P; Yang H; Zhang J; Soh BS; Li P; Lim SL; Cao S; Tay J; Orlov YL; Lufkin T; Ng HH; Tam WL; Lim B
    Nature; 2010 Feb; 463(7284):1096-100. PubMed ID: 20139965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of pluripotency and reprogramming.
    Na J; Plews J; Li J; Wongtrakoongate P; Tuuri T; Feki A; Andrews PW; Unger C
    Stem Cell Res Ther; 2010 Oct; 1(4):33. PubMed ID: 20974014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional foundation of pluripotency.
    Chambers I; Tomlinson SR
    Development; 2009 Jul; 136(14):2311-22. PubMed ID: 19542351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle and pluripotency: Convergence on octamer‑binding transcription factor 4 (Review).
    She S; Wei Q; Kang B; Wang YJ
    Mol Med Rep; 2017 Nov; 16(5):6459-6466. PubMed ID: 28901500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG.
    Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH
    Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of mouse induced pluripotent stem cells without viral vectors.
    Okita K; Nakagawa M; Hyenjong H; Ichisaka T; Yamanaka S
    Science; 2008 Nov; 322(5903):949-53. PubMed ID: 18845712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.